Steven J. Chmura

9.9k total citations · 1 hit paper
172 papers, 6.0k citations indexed

About

Steven J. Chmura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven J. Chmura has authored 172 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Pulmonary and Respiratory Medicine, 71 papers in Oncology and 49 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven J. Chmura's work include Advanced Radiotherapy Techniques (39 papers), Brain Metastases and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Steven J. Chmura is often cited by papers focused on Advanced Radiotherapy Techniques (39 papers), Brain Metastases and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (29 papers). Steven J. Chmura collaborates with scholars based in United States, Canada and United Kingdom. Steven J. Chmura's co-authors include Ralph R. Weichselbaum, Joseph K. Salama, Michael T. Milano, Sean P. Pitroda, Ashesh B. Jani, Daniel J. Haraf, Hania Al‐Hallaq, Ruth Heimann, Matthew Koshy and Everett E. Vokes and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Steven J. Chmura

169 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

2018 434 citations Jason J. Luke, Theodore Karrison et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven J. Chmura United States	39	2.5k	2.5k	1.4k	1.2k	1.0k	172	6.0k
Thomas Brunner Germany	43	1.9k 0.7×	2.9k 1.2×	1.5k 1.1×	843 0.7×	737 0.7×	170	5.9k
Bin S. Teh United States	48	4.0k 1.6×	2.0k 0.8×	2.0k 1.4×	1.6k 1.4×	1.9k 1.9×	374	8.4k
Martin Stuschke Germany	45	4.7k 1.9×	2.5k 1.0×	2.9k 2.1×	1.4k 1.2×	667 0.7×	334	8.3k
D. Azria France	46	2.8k 1.1×	3.4k 1.4×	2.3k 1.7×	2.0k 1.7×	1.2k 1.2×	372	7.6k
Mark De Ridder Belgium	39	2.1k 0.8×	1.4k 0.6×	614 0.4×	1.7k 1.5×	2.1k 2.0×	199	5.2k
Yuhchyau Chen United States	35	2.6k 1.0×	1.2k 0.5×	506 0.4×	1.1k 0.9×	767 0.7×	120	4.4k
F. Mornex France	40	3.7k 1.5×	3.0k 1.2×	2.5k 1.8×	1.1k 1.0×	1.1k 1.1×	272	7.0k
Jeffrey Y.C. Wong United States	43	1.8k 0.7×	1.5k 0.6×	669 0.5×	2.7k 2.3×	1.3k 1.3×	214	5.4k
Stephan Bodis Switzerland	34	1.4k 0.6×	1.7k 0.7×	478 0.3×	950 0.8×	459 0.4×	106	5.3k
Marianne Nordsmark Denmark	32	1.6k 0.6×	1.0k 0.4×	624 0.4×	1.6k 1.4×	486 0.5×	94	5.3k

Countries citing papers authored by Steven J. Chmura

Since Specialization

Citations

This map shows the geographic impact of Steven J. Chmura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Chmura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Chmura more than expected).

Fields of papers citing papers by Steven J. Chmura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Chmura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Chmura. The network helps show where Steven J. Chmura may publish in the future.

Co-authorship network of co-authors of Steven J. Chmura

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Chmura. A scholar is included among the top collaborators of Steven J. Chmura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Chmura. Steven J. Chmura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Yuzhu, Kaiting Yang, Liangliang Wang, et al.. (2024). Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites. Clinical Cancer Research. 30(9). 1945–1958. 23 indexed citations

Perez, Bradford A., Raid Aljumaily, Thomas U. Marron, et al.. (2024). Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors. ESMO Open. 9(2). 102217–102217. 10 indexed citations

Lyne, Séan, David J. Voce, Vinai Gondi, et al.. (2024). A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma. Neuro-Oncology Advances. 6(1). vdae014–vdae014. 4 indexed citations

Pusztai, Lajos, Peter Dubsky, Thomas Bachelot, et al.. (2023). De Novo Oligometastatic Breast Cancer. Journal of Clinical Oncology. 41(34). 5237–5241. 3 indexed citations

Juloori, Aditya, Gregory N. Gan, Jun Zhang, et al.. (2023). Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). TPS8615–TPS8615. 1 indexed citations

Carpenter, David, Jim Leng, John P. Kirkpatrick, et al.. (2023). Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases. JAMA Network Open. 6(4). e2310117–e2310117. 8 indexed citations

Karapetyan, Lilit, et al.. (2023). Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations. JNCI Journal of the National Cancer Institute. 115(11). 1278–1293. 12 indexed citations

Leng, Jim, David Carpenter, Muhammad Arshad, et al.. (2023). Multi-Institutional Outcomes Following Stereotactic Radiosurgery for Gastrointestinal Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 117(2). e146–e147. 1 indexed citations

Korpics, Mark, Rebekah Dadey, Lilit Karapetyan, et al.. (2023). Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases. Journal of Clinical Investigation. 133(10). 19 indexed citations

10.

Yang, Kaiting, Yuzhu Hou, Yuan Zhang, et al.. (2021). Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation. The Journal of Experimental Medicine. 218(3). 85 indexed citations

11.

Korpics, Mark, et al.. (2019). A Validated Radiomics T-cell Score Predicts Response to Multi-site SBRT Combined with Pembrolizumab. International Journal of Radiation Oncology*Biology*Physics. 105(1). S74–S74. 3 indexed citations

12.

Luke, Jason J., Sandeep R. Bhave, Theodore Karrison, et al.. (2019). Multi-Site SBRT and Sequential Pembrolizumab: Treated Metastasis Control and Immune-Related Expression Predict Outcomes. International Journal of Radiation Oncology*Biology*Physics. 104(5). 1190–1191. 5 indexed citations

13.

Arina, Ainhoa, Michael A. Beckett, Christian Fernandez, et al.. (2019). Tumor-reprogrammed resident T cells resist radiation to control tumors. Nature Communications. 10(1). 3959–3959. 161 indexed citations

14.

Melotek, J.M., C. Stepaniak, Steven J. Chmura, & Daniel W. Golden. (2015). Implementation and Evaluation of a Self-directed Dosimetry Curriculum for Radiation Oncology Residents. International Journal of Radiation Oncology*Biology*Physics. 93(3). E379–E380. 1 indexed citations

15.

Bergsma, D.P., Joseph K. Salama, Deepinder Singh, Steven J. Chmura, & Michael T. Milano. (2015). The evolving role of radiotherapy in treatment of oligometastatic NSCLC. Expert Review of Anticancer Therapy. 15(12). 1459–1471. 7 indexed citations

16.

Feng, Christine H., et al.. (2014). An Image-Guided Study of Setup Reproducibility of Postmastectomy Breast Cancer Patients Treated With Inverse-Planned Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 91(1). 58–64. 14 indexed citations

17.

Rudra, Sonali, Hania Al‐Hallaq, Christine H. Feng, Steven J. Chmura, & Yasmin Hasan. (2014). Effect of RTOG breast/chest wall guidelines on dose‐volume histogram parameters^*. Journal of Applied Clinical Medical Physics. 15(2). 127–137. 25 indexed citations

18.

Lussier, Yves A., Nikolai N. Khodarev, Kelly Regan, et al.. (2013). Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs. PLoS ONE. 8(6).

19.

Mell, Loren K., David A. Schomas, Joseph K. Salama, et al.. (2007). Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Anal Cancer Patients Treated With Concurrent Chemotherapy and Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 70(5). 1431–1437. 176 indexed citations

20.

Kochanski, J.D. & Steven J. Chmura. (2006). Is postmastectomy radiotherapy useful in elderly women with high-risk breast cancer?. Nature Clinical Practice Oncology. 3(8). 422–423. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact